Tillomed Laboratories

Latest clinical program signals indexed for Tillomed Laboratories.

1. CFA-1034-2-23 — Phase 1

   Jun 8, 2026
   Clinical update →

2. CFA-1034-1-23 — Phase 1

   Jun 8, 2026
   Clinical update →

3. CFA-1028-2-23 — Phase 1

   Jun 8, 2026
   Clinical update →

4. THEA_HLF_1/21 — Approved

   Jun 8, 2026
   Clinical update →

5. CFA-1048-2-25 — Phase 1

   Jun 8, 2026
   Clinical update →

6. CFA-1048-1-25 — Phase 1

   Jun 8, 2026
   Clinical update →

7. CFA-1037-1-24 — Phase 1

   Jun 8, 2026
   Clinical update →

8. BLCL-2ME-02 — Phase 1

   Jun 8, 2026
   Clinical update →

1. 2023-505908-28-00

   LT-02-19

   Phase 1 · active · other

   Chronic spontaneous urticaria, Allergic asthma, Chronic rhinosinusitis with nasal polyps

   CTIS ↗
2. 2023-506561-62-00

   Bioequivalence clinical trial of two formulations of dapagliflozin.

   Phase 1 · active · other

   Healthy volunteers

   CTIS ↗
3. 2023-506562-31-00

   Bioequivalence clinical trial of two formulations of linagliptin

   Phase 1 · active · other

   Healthy volunteers

   CTIS ↗
4. 2023-506844-18-00

   CFA-1028-2-23

   Phase 1 · active · other

   No medical condition.

   CTIS ↗
5. 2023-506938-68-00

   UECHUP-DON/23-5

   Phase 1 · active · other

   Alzheimer's disease

   CTIS ↗
6. 2023-509419-10-00

   CFA-1034-1-23

   Phase 1 · active · other

   No medical condition

   CTIS ↗
7. 2023-509422-21-00

   CFA-1034-2-23

   Phase 1 · active · other

   No medical condition.

   CTIS ↗
8. 2024-510791-20-00

   Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

   Phase 1 · active · other

   Healthy volunteers

   CTIS ↗
9. 2024-510795-20-00

   Bioequivalence clinical trial of two formulations of edoxaban.

   Phase 1 · active · other

   Healthy volunteers

   CTIS ↗
10. 2024-512310-18-00

    UECHUP-LIN-MET/24-1

    Phase 1 · active · other

    diabetes

    CTIS ↗
11. 2024-512311-41-00

    UECHUP-RAS/24-2

    Phase 1 · active · other

    Parkinson´s disease

    CTIS ↗
12. 2024-512596-12-00

    UECHUP-ATO/24-3

    Phase 1 · active · other

    Hypercholesterolaemia, Prevention of cardiovascular disease

    CTIS ↗
13. 2024-513480-37-00

    CFA-1037-1-24

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
14. 2024-513489-20-00

    CLOBOF3-17IA03

    Phase 3 · active · small_molecule

    Inflammation and pain associated with ocular surgery

    CTIS ↗
15. 2024-514050-75-01

    Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
16. 2024-515076-13-00

    Bioequivalence clinical trial of two formulations of linagliptin/metformin

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
17. 2024-515077-96-00

    Bioequivalence clinical trial of two formulations of bilastine.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
18. 2024-515238-34-00

    UECHUP-DAP/24-4

    Phase 1 · active · other

    Diabetes

    CTIS ↗
19. 2024-515531-29-00

    Bioequivalence clinical trial of two formulations of loperamide.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
20. 2024-516081-11-00

    Bioequivalence clinical trial of two formulations of linagliptin/metformin.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
21. 2024-516497-29-00

    UECHUP-VOR/24-5

    Phase 1 · active · other

    Antidepressant

    CTIS ↗
22. 2024-516854-23-00

    BLCL-2ME-01

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
23. 2024-518093-13-00

    THEA_HLF_1/21

    Approved · active · small_molecule

    Dry Eye and Meibomian Gland Dysfunction

    CTIS ↗
24. 2024-519398-21-00

    Bioequivalence clinical trial of two formulations of vortioxetine.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
25. 2024-520303-62-00

    Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
26. 2025-520736-41-00

    BLCL-ETN-ANV-01

    Phase 1 · active · other

    No medical condition

    CTIS ↗
27. 2025-520737-23-00

    BLCL-ETN-ANV-02

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
28. 2025-521549-26-00

    Bioequivalence clinical trial of two formulations of loperamide.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
29. 2025-521732-11-00

    CFA-1042-1-24

    Phase 1 · active · other

    No medical condition

    CTIS ↗
30. 2025-522124-26-00

    UECHUP-ESC/25-3

    Phase 1 · active · other

    Antidepressants

    CTIS ↗
31. 2025-522225-35-00

    UECHUP-EDO/25-2

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
32. 2025-522234-31-00

    The bioavailability study of Dapagliflozin

    Phase 1 · active · other

    not applicable (submitted trial is a bioequivalence study

    CTIS ↗
33. 2025-522254-39-00

    1019/25

    Phase 1 · active · other

    Bioavailability study in healthy volunteers under fed conditions.

    CTIS ↗
34. 2025-522412-16-00

    TioSMI

    Phase 1 · active · other

    Chronic obstructive pulmonary disease

    CTIS ↗
35. 2025-522624-27-00

    CFA-1048-1-25

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
36. 2025-522626-12-00

    CFA-1048-2-25

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
37. 2025-522627-10-00

    CFA-1048-3-25

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
38. 2025-523269-31-00

    SIE-1

    Phase 1 · active · other

    Hormone receptor-positive early breast cancer in post-menopausal women

    CTIS ↗
39. 2025-523300-77-00

    Bioequivalence of Testosterone Transdermal Gel in Healthy Female Participants.

    Phase 1 · active · other

    No medical conditions.

    CTIS ↗
40. 2025-523384-37-00

    Bioequivalence clinical trial of two formulations of linagliptin

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
41. 2025-523419-12-00

    BLCL-2ME-02

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
42. 2025-523705-14-00

    Bioequivalence clinical trial of two formulations of loperamide.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
43. 2025-523736-39-00

    2025-LIUD06004-PL-01

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
44. 2025-523808-75-00

    UECHUP-MEM/25-6

    Phase 1 · active · other

    Alzheimer’s disease

    CTIS ↗
45. 2025-524035-39-00

    1062/25

    Phase 1 · active · other

    Bioavailability study in healthy volunteers under fasting conditions.

    CTIS ↗
46. 2025-524102-15-00

    BLCL-ACB-PIL01

    Phase 1 · active · other

    No medical condition.

    CTIS ↗
47. 2026-525230-27-00

    Bioequivalence clinical trial of two formulations of rosuvastatin.

    Phase 1 · active · other

    Hypercholesterolemia

    CTIS ↗
48. 2026-525278-20-00

    Bioequivalence clinical trial of two formulations of loperamide.

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
49. 2026-525944-14-00

    Bioequivalence clinical trial of two formulations of canagliflozin

    Phase 1 · active · other

    Healthy volunteers

    CTIS ↗
50. 2026-526102-33-00

    CFA-1042-3-26

    Phase 1 · active · other

    No medical condition

    CTIS ↗
51. NCT05250141

    Levodopa 250mg and Carbidopa 25mg Test Drug tablet

    Phase 1 · completed · small_molecule

    Bioequivalence

    CT.gov ↗